Continuous Glucose Monitoring (CGM) is an advanced method for managing diabetes that provides real-time glucose readings throughout the day and night. Unlike traditional finger-prick tests, the CGM device uses a tiny sensor inserted under the skin to measure glucose levels in the interstitial fluid. The sensor sends this data to a display device, allowing users to see their glucose levels in real-time, track trends, and receive alerts for hypo and hyperglycemia.
Dexcom offers a variety of CGM devices with a wear period of 10 days. These devices provide continuous glucose readings every five minutes and feature customizable high and low alerts to notify users of at-risk blood glucose levels.
Every 3 Months:
Every 6 Months (G6 model only):
Every 5 Years:
The Abbott FreeStyle Libre system is designed for a wear period of up to 14 days. It stores historical glucose data, allowing users and healthcare professionals to review trends and make informed adjustments to diabetes management plans.
Every 3 Months:
FreeStyle Libre 2 replacement sensors (x7), or
FreeStyle Libre 3 replacement sensors (x7)
Every 5 Years:
New receiver
Continuous updates on glucose levels without frequent finger pricks
Notifications for high or low blood sugar levels.
Insight into glucose patterns over time.
Less invasive testing compared to traditional methods.
Allows caregivers and providers to track glucose levels remotely.
Easy sharing of glucose data with loved ones and healthcare providers.
In addition to our core services, we offer a range of additional resources to support our patients.
For any questions or concerns, please contact the appropriate team:
"*" indicates required fields
